(NasdaqGM:STIM), MALVERN, Pa., Aug. 04, 2025 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming the lives of patients whenever and wherever they need help, with the leading neurohealth therapies in the world, today announced that Keith Sullivan, President and Chief […]
(NASDAQ:RUBI), ATHENS, Greece, Aug. 04, 2025 (GLOBE NEWSWIRE) — Rubico Inc. (the “Company” or “Rubico”) (Nasdaq: RUBI) announced today that it has completed its spin-off from Tops Ships Inc. effective August 1, 2025. The Company's shares have commenced trading as of today, August 4, 2025, on the Nasdaq Capital Market under the ticker symbol “RUBI”.
INNOVATE Closes Indebtedness Refinancing Transactions INNOVATE's Maturity Profile Has Been Successfully Extended GlobeNewswire August 04, 2025 NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) — INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) today announced that it has closed a series of previously announced indebtedness refinancing transactions that will, among other things, exchange or amend existing
Knight Therapeutics and Incyte Amend Supply and Distribution Agreement to Add Retifanlimab and Axatilimab in Latin America GlobeNewswire August 04, 2025 MONTREAL, Aug. 04, 2025 (GLOBE NEWSWIRE) — Knight Therapeutics Inc., (TSX: GUD) (“Knight”) a pan-American (ex-USA) specialty pharmaceutical company, announced today that it has expanded its existing relationship and amended its agreement with Incyte
Vodafone and Kaltura Sign a Long-Term Partnership Agreement to Expand Cloud TV Services Already partners for over 10 years, the now extended partnership further strengthens Vodafone's Cloud TV market leadership across Europe throughout the next decade GlobeNewswire August 04, 2025 New York, Aug. 04, 2025 (GLOBE NEWSWIRE) — Vodafone Group PLC (Nasdaq: VOD) and Kaltura
Harvard Bioscience Schedules Second Quarter 2025 Earnings Conference Call for August 11, 2025 at 8:00 AM ET GlobeNewswire August 04, 2025 HOLLISTON, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended June 30, 2025, before the market opens on August 11, 2025, and
Mercado Libre Delivers Another Strong Performance in Q2'25, Reporting $6.8 billion Revenue and $825 million Income from Operations GlobeNewswire August 04, 2025 Montevideo, Aug. 04, 2025 (GLOBE NEWSWIRE) — Mercado Libre Delivers Another Strong Performance in Q2'25, reporting $6.8 billion revenue and $825 million income from operations In Commerce, items sold rose 31% YoY driven
LM Funding America Announces Second Quarter 2025 Earnings Call for August 14, 2025 GlobeNewswire August 04, 2025 TAMPA, Fla., Aug. 04, 2025 (GLOBE NEWSWIRE) — LM Funding America, Inc. (NASDAQ: LMFA) (“LM Funding” or the “Company”), a Bitcoin mining and technology-based specialty finance company, today announced that it has scheduled its second quarter 2025 earnings
Cellectis Reports Second Quarter 2025 Financial Results & Business Updates GlobeNewswire August 04, 2025 Cellectis to host an Investor R&D Day in New York City on October 16, 2025: Phase 1 dataset and late-stage development strategy for lasme-cel (UCART22) in r/r B-ALL to be presented End-of-Phase 1 meetings with FDA & EMA for lasme-cel (UCART22)
Onco360(R) Has Been Selected as a Specialty Pharmacy Partner for LYNOZYFIC(TM) (linvoseltamab-gcpt) GlobeNewswire August 04, 2025 LOUISVILLE, Ky., Aug. 04, 2025 (GLOBE NEWSWIRE) — Onco360(R), the nation's leading independent Specialty Pharmacy, has been selected as a national pharmacy partner by Regeneron Pharmaceuticals for Lynozyfic(TM) (linvoseltamab-gcpt), which has been has granted accelerated approval by the Food